BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27142681)

  • 21. Hearing preservation and tumour control after radiosurgery for NF2-related vestibular schwannomas.
    Massager N; Delbrouck C; Masudi J; De Smedt F; Devriendt D
    B-ENT; 2013; 9(1):29-36. PubMed ID: 23641588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal analysis of hearing before and after radiosurgery for vestibular schwannoma.
    Yomo S; Carron R; Thomassin JM; Roche PH; Régis J
    J Neurosurg; 2012 Nov; 117(5):877-85. PubMed ID: 22937934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term hearing outcomes after gamma knife surgery in patients with vestibular schwannoma with hearing preservation: evaluation in 92 patients with serial audiograms.
    Hasegawa T; Kato T; Yamamoto T; Naito T; Kato N; Torii J; Ishii K
    J Neurooncol; 2018 Jun; 138(2):283-290. PubMed ID: 29667085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.
    Nowak A; Dziedzic T; Czernicki T; Kunert P; Morawski K; Niemczyk K; Marchel A
    Neurol Neurochir Pol; 2015; 49(5):295-301. PubMed ID: 26377980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
    Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
    Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microsurgery for patients diagnosed with neurofibromatosis type 2 complicated by vestibular schwannomas: Clinical experience and strategy for treatments.
    Chen LH; Zhang HT; Xu RX; Zhang L; Li WD; Sun K
    Medicine (Baltimore); 2018 Apr; 97(17):e0270. PubMed ID: 29702972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up studies of Gamma Knife surgery with a low margin dose for vestibular schwannoma.
    Sun S; Liu A
    J Neurosurg; 2012 Dec; 117 Suppl():57-62. PubMed ID: 23205790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma Knife radiosurgery for vestibular schwannomas: evaluation of tumor control and its predictors in a large patient cohort in The Netherlands.
    Klijn S; Verheul JB; Beute GN; Leenstra S; Mulder JJ; Kunst HP; Hanssens PE
    J Neurosurg; 2016 Jun; 124(6):1619-26. PubMed ID: 26430848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor Control and Hearing Preservation After Gamma Knife Radiosurgery for Vestibular Schwannomas in Neurofibromatosis Type 2-A Retrospective Analysis of 133 Tumors.
    Sri Krishna GS; Pahwa B; Jagdevan A; Singh M; Kale S; Agrawal D
    World Neurosurg; 2023 Mar; 171():e820-e827. PubMed ID: 36587894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose radiosurgery for large vestibular schwannomas: long-term results of functional preservation.
    Inoue HK
    J Neurosurg; 2005 Jan; 102 Suppl():111-3. PubMed ID: 15662791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsurgery for vestibular schwannoma after gamma knife radiosurgery.
    Shuto T; Inomori S; Matsunaga S; Fujino H
    Acta Neurochir (Wien); 2008 Mar; 150(3):229-34; discussion 234. PubMed ID: 18253695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
    Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
    Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preservation of hearing in vestibular schwannomas treated by radiosurgery using Leksell Gamma Knife: preliminary report of a prospective Belgian clinical study.
    Delbrouck C; Hassid S; Massager N; Choufani G; David P; Devriendt D; Levivier M
    Acta Otorhinolaryngol Belg; 2003; 57(3):197-204. PubMed ID: 14571654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term safety and efficacy of stereotactic radiosurgery for vestibular schwannomas: evaluation of 440 patients more than 10 years after treatment with Gamma Knife surgery.
    Hasegawa T; Kida Y; Kato T; Iizuka H; Kuramitsu S; Yamamoto T
    J Neurosurg; 2013 Mar; 118(3):557-65. PubMed ID: 23140152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls.
    Carlson ML; Tveiten OV; Driscoll CL; Goplen FK; Neff BA; Pollock BE; Tombers NM; Castner ML; Finnkirk MK; Myrseth E; Pedersen PH; Lund-Johansen M; Link MJ
    J Neurosurg; 2015 Apr; 122(4):833-42. PubMed ID: 25555165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Fractionated Gamma Knife Radiosurgery a Safe and Effective Treatment Approach for Large-Volume (>10 cm
    Han MS; Jang WY; Moon KS; Lim SH; Kim IY; Jung TY; Jung S
    World Neurosurg; 2017 Mar; 99():477-483. PubMed ID: 28017757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional outcome after gamma knife surgery or microsurgery for vestibular schwannomas.
    Régis J; Pellet W; Delsanti C; Dufour H; Roche PH; Thomassin JM; Zanaret M; Peragut JC
    J Neurosurg; 2002 Nov; 97(5):1091-100. PubMed ID: 12450031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation.
    Phi JH; Kim DG; Chung HT; Lee J; Paek SH; Jung HW
    Cancer; 2009 Jan; 115(2):390-8. PubMed ID: 19109818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gamma knife surgery for trigeminal schwannoma.
    Sheehan J; Yen CP; Arkha Y; Schlesinger D; Steiner L
    J Neurosurg; 2007 May; 106(5):839-45. PubMed ID: 17542528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2.
    Moffat DA; Lloyd SK; Macfarlane R; Mannion R; King A; Rutherford S; Axon PR; Donnelly N; Freeman S; Tysome JR; Evans DG; Ramsden RT
    Br J Neurosurg; 2013 Aug; 27(4):446-53. PubMed ID: 23472624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.